Serum Institute of India (SII) CEO Adar Poonawalla on January 22 informed that there is no impact of fire on the production of 'Covishield' vaccine. "The extent of the damage is more than 1,000 crores. The supply of COVID-19 will not be affected due to the fire (at Serum Institute of India facility). No actual vaccine was being made at that facility. The fire has no impact on the production of 'Covishield' vaccine and no damage has occurred to the existing stock either," said Adar Poonawalla. A major fire had occurred at Pune-based Serum Institute of India (SII) on January 21 that claimed 5 lives also.
India once again established its position as a reliable partner in Covid-19 assistance. It dispatched Covishield to Bahrain and Sri Lanka under the Vaccine Maitri Initiative. Sri Lanka to receive a consignment of 50,400 doses, while Bahrain to get 10,800 doses. Covishield developed by Serum Institute of India was loaded to cargo aircraft at Mumbai. The cargo aircraft left Mumbai airport as per schedule at 7:55 am for Manama. The vaccine consignment for Colombo, which delayed for 15 minutes, left at 9:00 am. Meanwhile, India has supplied vaccines to its neighbours under neighbourhood first policy. Bhutan, Maldives, Nepal, Myanmar, Sri Lanka, Afghanistan, Bangladesh received vaccines. India sees international cooperation in the area of fight against Covid-19 as its duty. New Delhi has played the role of the first responder in the region.
Credit: HT Digital Content Duration: 01:29Published
Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 28. The consignment containing COVID-19 vaccine will be dispatched to Bahrain and Colombo today. India is helping other countries with the import of COVID vaccine amid the pandemic.
Cyrus S Poonawalla, chairman and MD of Serum Institute of India, on Thursday said the vaccine major will offer compensation of Rs 25 lakh in addition to the mandated amount to families of persons who..
Credit: HT Digital Content Duration: 03:00Published
Serum Institute of India (SII), CEO Adar Poonawalla received a COVISHIELD vaccine shot on January 16. COVISHIELD vaccine is manufactured by SII. India has approved 2 vaccines - Covishield and Covaxin...
Russian envoy in New Delhi Nikolay Kudashev on Monday said Moscow will jointly produce the Sputnik V vaccine for Covid-19 along with India and it will be... IndiaTimes Also reported by •Zee News •Mid-Day